Sexually transmitted infections (STI) are a great human public health concern. During the last decade, public surveys have revealed decreases in the number of syphilis, genital Chlamydia trachomatis, gonococcal, genital herpes virus and Condyloma acuminata infections, with a concomitant increase of HIV/AIDS patients in Japan. In this article, we review the current topics of STI including their epidemiology, prevention and treatment. Unprotected sexual behavior increases infection sites not only of the genital organs but also the pharynx and rectum, while the role of oral contraceptives remains controversial. The increase of antibiotic-resistant Neisseria gonorrhoeae has been reported in many countries. In the treatment of HIV/AIDS, antiretroviral therapy (ART) can suppress the viral load and reduce HIV-related morbidity and mortality. Recently, the new concept of "Treatment as prevention" has been raised because the suppression of viral load by ART significantly decreases the risk of HIV transmission. Cervical cancer and Condyloma acuminata occur after persistent infection with a specific subset of human papillomavirus (HPV) types. Two prophylactic HPV vaccines derived from HPV-16/18 and HPV-6/11/16/18 are presently available. These vaccines have dramatically decreased HPVrelated genital neoplasms but do not cover all viral types. Due to the essential nature of sexual activities and human reproduction, it is quite difficult to eradicate STI completely. However, we believe that we can control most STIs with appropriate use of vaccines, antimicrobial drugs and educating the public about safer sex. Thus, STI specialists and general practitioners should be provided with sufficient information regarding recent trends of STI diagnosis and management.
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